Lv32
320 积分 2024-09-21 加入
GLP-1 Receptor Agonist Orforglipron for Adults with Obesity
41分钟前
已完结
A 16 Week Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With Type 2 Diabetes Mellitus
15小时前
求助中
Effect of Orforglipron versus Placebo and Dulaglutide on Glycemic Control and Body Weight in Patients with Type 2 Diabetes
17小时前
已完结
Effect of Orforglipron versus Placebo and Dulaglutide on Glycemic Control and Body Weight in Patients with Type 2 Diabetes
17小时前
已关闭
Efficacy and safety of oral orforglipron in patients with type 2 diabetes: a multicentre, randomised, dose-response, phase 2 study
20小时前
已完结
In obesity or overweight without diabetes, orforglipron increased weight loss at 26 wk
23小时前
已完结
皖公网安备34019202002308
